NewGenIVF Group announced a strong fiscal year 2025 with total assets reaching $32.7 million, up from $3.6 million the previous year, and a net profit of $9.9 million mainly due to gains from acquiring Nodexus and Microsort businesses. The company also completed a $17.9 million valuation of advanced cytometry intellectual property, contributing to a $19.2 million bargain purchase gain. NewGen is advancing its diversification strategy through digital assets and health supplements, supported by a $2 million share repurchase program reflecting management confidence. These results highlight NewGen's successful transformation and position it for continued growth across real estate, digital innovation, and healthcare sectors.
Perplexity AI CEO Aravind Srinivas shared lessons from Nvidia's Jensen Huang and Tesla's Elon Musk, highlighting Huang's mindset of running Nvidia as if it could fail within 30 days despite its $5 trillion valuation and advanced technology. Srinivas ...
Meta Platforms introduced an AI-powered feature called "AI Mode" within Facebook Search, which uses Meta's AI model Muse Spark to provide answers from public content rather than traditional search results. This innovation could generate over $10 bill...
Cuprina Holdings shares surged 111.84% intraday following FDA 510(k) clearance for its MEDIFLY Maggots wound care product, the first maggot debridement therapy using Lucilia cuprina species approved in the U.S. The product treats non-healing necrotic...
Cortea secured €12 million in funding led by Dawn Capital to develop AI-powered Audit Quality Agents that review audit reports and financial statements, identifying errors and inconsistencies before sign-off. These tools help audit firms improve qual...
Cortea secured €12 million in seed funding led by Dawn Capital to develop AI tools that enhance audit quality without compromising accuracy. Their Audit Quality Agents review audit reports and financial statements to detect inconsistencies and errors...
